ChE Professor Debra Auguste is collaborating with Boston Children's Hospital to develop new treatments to target and treat patients with triple-negative breast cancer.
You are here
News Related to Debra Auguste
April 3, 2019
April 1, 2019
ChE Professor Debra Auguste's article on "Targeted Lipid Nanoemulsions Encapsulating Epigenetic Drugs Exhibit Selective Cytotoxicity on CDH1/FOXM1+ Triple Negative Breast Cancer Cells" published in Molecular Pharmaceutics.
March 21, 2019
Chemical Engineering Professor Debra Auguste’s research paper, Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis, was recently published in Sciences Advances journal.
October 9, 2018
MBF Bioscience recently selected ChE PhD student Danielle Large as a NeuroArt winner and her work was featured on the cover image of the November 2018 issue of the Journal of Neuroscience Research.
September 25, 2018
ChE Professor Debra Auguste was featured in the lastest Virtual Issue of Bioconjugate Chemistry from ACS (American Chemical Society). The article is titled "Women in Bioconjugate Chemistry:...
September 11, 2018
ChE Professor Debra Auguste was selected as a member of the Board of Directors for the Biomedical Engineering Society (BMES), the lead society and professional home for biomedical engineering and bioengineering.
August 28, 2018
ChE Professor Debra Auguste has been selected as a fellow of the Biomedical Engineering Society (BMES) for her exceptional achievements and significant contributions within the biomedical engineering field.
July 9, 2018
ChE Professor Debra Auguste is researching a different way to approach cancer treatment without taking an extreme toll on patients.
September 16, 2016
New ChE Professor Debra Auguste is studying human biology to develop better medical therapies and drug delivery methods.
September 1, 2016
Debra Auguste joins the Chemical Engineering department in Fall 2016 as a Professor.